Abstract:Background: Pathophysiological processes underlying diabetic-related cardiomyopathies are complex. Mitochondria dysfunction is often described as a cause of cardiac impairment but its extent may depend on the type of experimental diabetes. Here we proposed to compare drug- or diet-induced models of diabetes in terms of metabolic features, cardiac and mitochondrial functions. Methods: Mice were fed with regular chow or fat-enriched diet. After three weeks, they received either citrate or streptozotocin injections for five consecutive days. Metabolic parameters, myocardial contractile function and mitochondrial respiration were measured after three more weeks. Fat mass volumes were assessed by magnetic resonance imaging. Oral glucose tolerance test, insulin tolerance test, triglyceride and adipocytokine quantification were evaluated to establish metabolic profiles. Cardiac function was assessed ex vivo onto a Langendorff column. Isolated cardiac mitochondria respiration was obtained using high-resolution oxygraphy. Results: Mice fed with the fat-enriched regimen presented abdominal obesity, increased blood glucose, elevated leptin level, glucose intolerance, and insulin resistance. Mice treated with streptozotocin, independently of the regimen, lost their capacity to release insulin in response to glucose ingestion. Mice fed with regular chow diet and injected with streptozotocin developed cardiac dysfunction without mitochondrial respiration defect. However, both groups of high-fat diet fed mice developed cardiac alterations associated with reduction in mitochondrial oxygen consumption, despite an increase in mitochondrial biogenesis signalling. Conclusions: We explored three animal models mimicking type 1 and 2 diabetes. While cardiac dysfunction was present in the three groups of mice, mitochondrial respiration impairment was only obvious in models reproducing features of type 2 diabetes.

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

Application of Animal Models in Diabetic Cardiomyopathy

Small Mammalian Animal Models of Heart Disease.

Current landscape of preclinical models of diabetic cardiomyopathy

Study of the pathogenesis and treatment of diabetes mellitus through animal models

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Future Perspective of Diabetic Animal Models

An Overview Of Valuable Scientific Models For Diabetes Mellitus

A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates

Animal Models for Cardiovascular Research

Large Mammalian Animal Models of Heart Disease

Cardiac contractile function and mitochondrial respiration in diabetes-related mouse models

Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal Models

Myocardial Ischemia-Reperfusion and Diabetes: Lessons Learned From Bedside to Bench

From Animal Models to Clinical Practicality: Lessons Learned from Current Translational Progress in Diabetic Peripheral Neuropathy Research

Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy

Spontaneous Type 2 Diabetic Rodent Models

Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy

Experimental animal models for diabetes and its related complications—a review

Goto-Kakizaki Rats: Its Suitability As Non-Obese Diabetic Animal Model For Spontaneous Type 2 Diabetes Mellitus

Matching model with mechanism: Appropriate rodent models for studying various aspects of diabetes pathophysiology